Search Result for : Indian Pharma Sector

Sneha Gilada Pharmaceuticals contribute as much as 5% to all Indian exports, and US is the biggest export market for Indian pharma, contributing one-third of total pharma exports. Naturally, the big names in Indian pharma are experiencing jitters from Trump's recent protectionist utterances.  At Bio Asia 2017, in an exclusive with Matt Szuhaj, MD, Deloitte Consulting LLP, San Francisco, The Dollar Business explores the extent of disruption the new political developments in America could cause. What is the present corporate tax scenario in USA?  Let me give you a broader context. Outside of the administration change in US, there was an effort by the OECD countries called base erosion and profit shifting. This was a process of trying to harmonise tax codes between countries. Essentially, they wanted more visibility, more transparency, and less individual agreements for specific ...

The Dollar Business Bureau  Indian pharma manufacturer Granules India said on Friday that it has got 11 observations from INFARMED - the health authority of Portugal, for its manufacturing unit situated at Gagillapur in the state of Telangana.  “INFARMED had conducted a renewal inspection of the facility. In this respect, the company has received the inspection report with 11 observations,” said Granules India in a regulatory filing.   INFARMED is a Government agency of Portugal accountable to the Health Ministry that evaluates, regulates, authorises, and controls health products as well as human medicines. The Gagillapur plant of the company manufactures finished dosages and pharmaceutical formulation intermediates (PFIs).  The Indian drug maker said that it has started taking necessary steps for addressing the observations of the Portuguese inspection agency and ...

The Dollar Business Bureau Players engaged in Business Process Outsourcing (BPO) in healthcare sector in India are facing stiff competition from their Filipino counterparts, said a study titled ‘Medical Process Outsourcing in India’. The joint study by Associated Chambers of Commerce and Industry of India (ASSOCHAM) and Ernst & Young (E&Y) described the Philippines and other low-cost locations as a big challenge to Indian healthcare BPO industry. “Competition from leading healthcare BPO companies in the United States is a big challenge for Indian vendors, since most of them are specialists in the healthcare sector and provide an increased gamut of services as compared to Indian vendors,” the study said. Lack of clarity in terms of laws related to taxation, data privacy, ...